Photo of Bexis

We have blogged several times before about the litigation misadventures of MSP Recovery, Inc., known for bringing Medicare recovery actions of questionable merit based on assignments of questionable validity that they obtain from various Medicare Advantage Plans looking for free money.  Occasionally, MSP has branched also filed RICO claims of an equally dubious nature.

In Series 17-03-615 v. Teva Pharmaceuticals USA, Inc., 2025 WL 1257677 (D. Kan. April 30, 2025), this would-be Medicare troll got trolled again, in yet another purported RICO class action.  Five defendants filed five motions to dismiss – and they were all granted.  Id. at *1.  On most issues, the five motions raised similar grounds:  lack of standing, lack of personal jurisdiction, and failure to state a claim.  Id. at *12. That led to the plaintiffs’ monumental procedural mistake.  Rather than bother to file separate responses to the five defendants’ motions, plaintiffs filed responsive papers that merely incorporated their responses to other defendants’ arguments by reference.  “[P]laintiffs filed responses to each of the five motions to dismiss” but “aggregated their responses to similar arguments which multiple defendants raised.”  Id.Continue Reading Would-Be Litigation Troll Trolled Again

Photo of Eric Alexander

We often say here that we try not to do the other side’s homework for them or give them ideas about new ways to sue our clients.  When the Supreme Court takes a well-known statute and says, essentially, that it can now be applied in personal injury cases that also have economic damages, we do

Photo of Stephen McConnell

We have often characterized judicial options as mixed bags, and a recent example of such a mixed bag can be found in Muldoon v. DePuy Orthopaedics, Inc., 2024 U.S. Dist. LEXIS 130020 (N.D. Cal. July 23, 2024). The plaintiff claimed injuries from a ceramic-on-metal hip implant.  He alleged that friction and wear caused the

Photo of Lisa Baird

No surprise, we are not fans of civil RICO.  We don’t like how it is misused by lawyers on the other side to convert run-of-the-mill pharmaceutical and medical device cases into class actions.  We don’t like that it carries the possibility of treble damages and attorneys’ fees.  We don’t like the elasticity of its terms. 

Photo of Steven Boranian

We often marvel at how plaintiffs’ attorneys find new ways to sue businesses, including under RICO.  Take for example the ever-increasing number of “MSP” plaintiffs that we are seeing in the published opinions.  We see plaintiffs called MSP Recovery, MSPA Claims, MSP Series, MSP-MAO, etc., and we are told that many or all of them